دورية أكاديمية

Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp.

التفاصيل البيبلوغرافية
العنوان: Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp.
المؤلفون: Trang T. Ly, Breton, Marc D., Keith-Hynes, Patrick, De Salvo, Daniel, Clinton, Paula, Benassi, Kari, Mize, Benton, Chernavvsky, Daniel, Place, Jéróme, Wilson, Darrell M., Kovatchev, Boris P., Buckingham, Bruce A., Ly, Trang T
المصدر: Diabetes Care; Aug2014, Vol. 37 Issue 8, p2310-2316, 7p, 1 Color Photograph, 1 Chart, 2 Graphs
مصطلحات موضوعية: INFUSION therapy equipment, BLOOD sugar, TYPE 1 diabetes, DIABETES in children, DIABETES, BLOOD sugar monitors, BIOSENSORS, ALGORITHMS, AUTOMATION, CAMPING, CIRCADIAN rhythms, CLINICAL trials, COMPARATIVE studies, HYPOGLYCEMIC agents, INSULIN, INSULIN pumps, RESEARCH methodology, MEDICAL cooperation, RESEARCH, EVALUATION research, RANDOMIZED controlled trials, EQUIPMENT & supplies
مستخلص: Objective: To determine the safety and efficacy of an automated unified safety system (USS) in providing overnight closed-loop (OCL) control in children and adolescents with type 1 diabetes attending diabetes summer camps. Research Design and Methods: The Diabetes Assistant (DIAS) USS used the Dexcom G4 Platinum glucose sensor (Dexcom) and t:slim insulin pump (Tandem Diabetes Care). An initial inpatient study was completed for 12 participants to evaluate safety. For the main camp study, 20 participants with type 1 diabetes were randomized to either OCL or sensor-augmented therapy (control conditions) per night over the course of a 5- to 6-day diabetes camp. Results: Subjects completed 54 OCL nights and 52 control nights. On an intention-to-treat basis, with glucose data analyzed regardless of system status, the median percent time in range, from 70-150 mg/dL, was 62% (29, 87) for OCL nights versus 55% (25, 80) for sensor-augmented pump therapy (P = 0.233). A per-protocol analysis allowed for assessment of algorithm performance. The median percent time in range, from 70-150 mg/dL, was 73% (50, 89) for OCL nights (n = 41) versus 52% (24, 83) for control conditions (n = 39) (P = 0.037). There was less time spent in the hypoglycemic range <50, <60, and <70 mg/dL during OCL compared with the control period (P = 0.019, P = 0.009, and P = 0.023, respectively). Conclusions: The DIAS USS algorithm is effective in improving time spent in range as well as reducing nocturnal hypoglycemia during the overnight period in children and adolescents with type 1 diabetes in a diabetes camp setting. [ABSTRACT FROM AUTHOR]
Copyright of Diabetes Care is the property of American Diabetes Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:01495992
DOI:10.2337/dc14-0147